期刊文献+

HPV11-E7与人干扰素α-2b融合表达质粒的构建及表达 被引量:1

Construction and Expression of Plasmid Coexpressing Human Papillomavirus Type 11 E7 and Human IFNα-2b
原文传递
导出
摘要 目的构建HPV11-E7与人干扰素a-2b(IFNa-2b)融合基因表达载体,并进行原核表达。方法通过连接肽将HPV11-E7与人IFNa-2b连接并克隆至原核表达载体pE7-32a,进行酶切鉴定及DNA序列分析。将重组质粒转染E.coli BL21,经IPTG诱导后对其表达产物进行SDS-PAGE和Westernblotting分析。结果测序结果表明将HPV11-E7和人IFNa-2b通过连接肽(G-G-S-G-S)_3连接并克隆至pET-32a,且其基因序列与设计完全一致。SDS-PAGE和Western blotting分析结果均显示在相对分子质量约50 000位置可见明显蛋白条带。结论 HPV11-E7与人IFNa-2b融合基因表达载体的成功构建及表达,为今后的相关实验研究奠定了基础。 Objective To construct an expression plasmid of human papillomavirus type 11 E7 (HPV11-E7)/human IFNα-2b fusion gene,to express the fusion gene in E.coli BL21, and pave way for further immunological study, Methods The recombinant plasmid was introduced into E.coli BL21, then the expression product was analyzed by SDS-PAGE and Western blotting after induction with isopropy-β-D-thiogalactoside (IPTG). Results The fusion gene of HPVll-E7 and human IFNα-2b was successfully cloned into pET-32a by a linker with the same sequence as we expected, The expressed fusion protein was confirmed by SDS-PAGE and Western blotting. Conclusions The successful construction of prokaryotic expression plasmid and expression of HPV11-E7/human IFNα-2b fusion gene enable further immunological study.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2005年第10期640-642,共3页 Chinese Journal of Dermatology
基金 江苏省重点学科基金(135-03)
关键词 尖锐湿疣 人乳头瘤病毒 E7基因 IFNΑ-2B 融合基因 干扰素α-2b 融合表达质粒 BLOTTING Western 基因表达载体 Condyloma accuminatum Human papillomavirus E7 gene IFNα-2b Fusion gene
  • 相关文献

参考文献7

  • 1Berry JM, Palefsky JM. A review of human papillomavirus vaccines:from basic science to clinical trials. Front Biosci, 2003, 8: S333-S345.
  • 2Chow YH, Huang WL, Chi WK, et al. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol, 1997, 71: 169-178.
  • 3Iida T, Kuwata T, Ui M, et al. Augmentation of antigen-specific cytokine responses in the early phase of vaccination with a live-attenuated simian/human immunodeficiency chimeric virus expressing IFN-gamma. Arch Virol, 2004, 149: 743-757.
  • 4McCormick AL, Thomas MS, Heath AW. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120. J Infect Dis, 2001,184: 1423-1430.
  • 5Congilosi SM, Madoff RD. Current therapy for recurrent and extensive anal warts. Dis Colon Rectum, 1995, 38:1101-1107.
  • 6Coleman N, Birley HD, Renton AM, et al. Immunological events in regressing genital warts. Am J Clin Pathol, 1994, 102: 768-774.
  • 7卿玉玲,赵嘉将,任红.乙型肝炎HBsAg和GM-CSF融合表达质粒的构建及表达[J].免疫学杂志,2003,19(3):201-204. 被引量:9

二级参考文献8

  • 1Sedegah M, Weiss W, Sacci JB Jr, et al. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant pox virus[J]. J Immunol, 2000 164(11):5905-5912.
  • 2Weiss WR, Ishii KJ, Hedstrom RC, et al. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine[J].J Immunol, 1998,161(5) :2325 - 2332.
  • 3Ishii KJ, Weiss WR, Klinman DM. Prevention of neonatal tolerance by a plasmid encoding granulocyte-macrophage colony stimulating factor[J]. Vaccine, 1999, 18(7- 8):703 - 710.
  • 4Burger JA, Mendoza RB, Kipps TJ. Plasmids encoding granulocyte- macrophage colony-stimulating factor and CD154 enhance the immune response to genetic vaccines[J]. Vaccine,2001 , 19( 15 - 16) :2181 - 2189.
  • 5Flo J, Beatriz Perez A, Tisminetzky S, et al. Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene[J]. Vaccine,2000, 18(28) :3242 - 3253.
  • 6Chow YH, Chiang BL, Lee YL, et al. Development of TⅢ and TH2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes [ J ]. J Immunol, 1998,160(3):1320- 1329.
  • 7Chow YH, Huang WH, Chi WK, et al. Improvement of hepatitis B virus DNA vaccine by plasmids co-expressing hepatitis B surface antigen and interleukin-2[J]. J Virol,1997,71(1):169- 178.
  • 8孙强明,戴长柏,李洪钊,丁云菲,马雁冰,刘红岩,徐维明.huIL-6-GM-CSF(9-127)融合蛋白的表达及活性测定[J].免疫学杂志,2002,18(4):253-257. 被引量:4

共引文献8

同被引文献7

  • 1相文忠,王飞,王群,刘丰,张兆松,苏川,毕志刚.人乳头瘤病毒E7与人干扰素α-2b融合基因在中国仓鼠卵巢细胞中的表达[J].临床皮肤科杂志,2006,35(7):430-432. 被引量:1
  • 2Chow YH, Huang WL, Chi WK, et al. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol, 1997, 71 (1): 169-178.
  • 3Barouch DH, Letvin NL, Seder RA. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol Rev, 2004, 202(3 ): 266-274.
  • 4Hsu KF, Hung CF, Cheng WF, et al. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther, 2001, 8(5): 376-383.
  • 5Chen CH, Wang TL, Hung CF, et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res, 2000, 60(4): 1035-1042.
  • 6Tracey L, Spiteri I, Ortiz P, et al. Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma. J Interferon Cytokine Res, 2004, 24(3): 185-195.
  • 7Jonasch E, Haluska FG. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist, 2001, 6 (1): 34-55.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部